Physician profile
Brian E Mendoza
NPI 1316444946
$3,522.07
in general payments reported to CMS, 2019-2025
6 companies · $3,221 in 2025
The $3,221 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $133 · 2024: $168 · 2025: $3,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,668 · Consulting Fee: $1,071 · Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,667.54 |
| Consulting Fee | $1,071.43 |
| Food and Beverage | $783.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Medical Systems Corporation | $1,500.00 | 2025 | Evis Exera II Ultrasound Gastrovideoscope |
| Boston Scientific Corporation | $1,474.59 | 2025 | Spyglass |
| Gilead Sciences, INC. | $167.71 | 2024 | |
| Conmed Corporation | $142.60 | 2025 | Conmed Dilation |
| Regeneron Pharmaceuticals, INC. | $133.21 | 2023 | Dupixent |
| Capsovision, INC. | $103.96 | 2025 | Capsocam Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mendoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.